Fellows of the British Pharmacological Society are members who have demonstrated distinction and peer recognition in pharmacology.
Fellows have made, and may continue to make, substantial contributions to the disciplines of pharmacology, clinical pharmacology and therapeutics, through their work, publication and presentation of research, leadership, and contribution to Society life.
Find out more and apply for Fellowship.
This directory has been created to increase the visibility of our Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Fellows with similar areas of interest.
Here you can find profiles of each Fellow, including information on their institutional affiliation, year elected, primary professional setting, affinity group membership, and a short biography.
Select the magnifying glass icon to begin any searches.
Leigh completed her CASE PhD in molecular pharmacology on the then newly deorphansied free fatty acid G protein-coupled receptors (GPCRs) at the University of Glasgow, under the supervision of Prof Graeme Milligan.
I read Pharmacy at the School of Pharmacy, London (1969) and then I accepted an MRC Scholarship to undertake research for a PhD under Laurence Malcolm at Aberdeen, where I used microiontophoresis to study the pharmacology of individual, physiologically identified neurons in the neocortex.
Dr Jennifer Stott is a Senior Lecturer at St George’s University of London, being part of the core team that established the first BSc in Clinical Pharmacology.
Lisa completed her CASE PhD in 2016 at the University of Nottingham, under the supervision of Dr Nicholas Holliday and Prof Stephen Hill (Nottingham), and Dr David Hall (GSK).
Although Philip Strange trained as an organic chemist in Cambridge, he was inexorably drawn to pharmacology through postdoctoral studies with Dan Koshland in Berkeley and Arnold Burgen at Mill Hill.
Professor Struthers graduated MB (Hons) in 1977.
Professor Szabo's expertise include oxidative and nitrosative stress, gaseous transmitters (nitric oxide, hydrogen sulfide), critical illness, cardiovascular and inflammatory diseases and cancer.
Juan Tamargo is Professor of Pharmacology in the School of Medicine of the University Complutense of Madrid.
Teresa Tejerina is Professor of Pharmacology in the School of Medicine of Universidad Complutense de Madrid (Spain).